# FDA 483 - Kevin R. Bender, M.D. - December 16, 2022

Source: https://www.keypedia.com/records/483/kevin-r-bender-md/194179ed-555a-4ffa-a09d-58e4bfd488e4

> FDA 483 for Kevin R. Bender, M.D. on December 16, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kevin R. Bender, M.D.
- Inspection Date: 2022-12-16
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: DBC Research Corp., a clinical investigator in Tamarac, FL, was inspected by the FDA and received a Form 483 with three observations. The findings indicate significant issues with the control and accountability of investigational drugs, including the loss of a controlled substance shipment. Additionally, the firm failed to maintain accurate and contemporaneous subject source documents regarding investigational product disposition and case histories, with instances of improper attribution of tasks.

## Related Officers

- [Angelica M. Chica](https://www.keypedia.com/people/angelica-m-chica/117a5aa3-e5ed-46f2-bf32-885591c34848)

Company: https://www.keypedia.com/companies/kevin-r-bender-md/8d58217d-bb30-4c21-8c07-fa25c92be1a7

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6